Croatia plans import agency for expensive drugs
This article was originally published in Scrip
Croatia’s health ministry may establish a new non-profit state agency with the exclusive right to import particularly expensive medicines from manufacturers, as some intermediaries in their supply chains apply up to 50% trade mark-ups. If implemented, the move could save up to €8.2 million, reports Scrip’s correspondent in Zagreb. These products are intended for around 400 patients and are expected to cost almost €55 million this year. The existing agency responsible for providing these drugs may be up to about €9.5 million short of funds, as the government initially allocated €27 million and then added just €6.8 million to cover the expected shortfall.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.